Adiponectin gene therapy

Details Adiponectin gene therapy Adiponectin gene therapy

2005-11-22

2005-11-22

Woitach, Joseph (Department: 1635)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C435S455000, C435S456000

Reexamination Certificate

active

06967018

ABSTRACT:
Adiponectin cDNA was cloned into AAV serotypes 1, 2, and 5-based expression vectors. Virions containing these vectors were administered to the livers of rat subjects via portal vein injection. A single injection of 6×1011virions of the vector caused a sustained and statistically significant reduction in body weight of the treated animals compared to the control animals. This occurred in the absence of side effects. Compared to control animals, the subject rats also exhibited reduced adipose tissue mass, reduced appetite, improved insulin sensitivity, and improved glucose tolerance.

REFERENCES:
patent: 5858351 (1999-01-01), Podsakoff et al.
patent: 2003/0100500 (2003-05-01), Fruebis et al.
patent: WO 01/32868 (2001-05-01), None
Anderson et al., Nature, vol. 392, pp. 25-30, 1998.
Verma, Nature, vol. 389, pp. 239-242, 1997.
Kmiec, American Scientist, 1999, 87, 240-247.
Juengst, BMJ, 2003, 326: 1410-11.
Orkin et al., Dec. 7, 1995, “Report and Recommendation of the Panel to Assess the NIH investment in Research and Gene Therapy”, issued by the National Institute of Health.
Monahan et al., Molecular Medicine Today, 2000, 4: 433-440.
Okamoto et al., “Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice,” Circulation, 22: 2767, 2002.
Scherer et al., “A novel Serum Protein Similar to Clq, Produced Exclusively in Adipocytes,” The Journal of Biological Chemistry, 270: 26746-26749, 1995.
Hu et al., “AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity,” The Journal of Biological Chemistry, 271: 10697-10703, 1996.
Maeda et al., “cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (Adipose Most Abundant Gene Transcript 1),” Biological and Biophysical Research Communications, 221: 286-289, 1996.
Nakano et al., “Isolation and Characterization of GBP28, a Novel Gelatin-Binding Protein Purified from Human Plasma,” J. Biochem, 120: 803-812, 1996.
Arita et al., “Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity,” Biochemical and Biophysical Research Communication, 257: 79-83, 1999.
Fruebis et al., “Proteolytic cleavage product of 30-kDA adipocyte Complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice,” PNAS, 98: 2005-2010, 2001.
Yamauchi et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, 7: 941-946, 2001.

Affiliated with

Also associated with

Rating

Adiponectin gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adiponectin gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adiponectin gene therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3482108